National Pharmaceutical Pricing Authority

STUDY OF CC, PC, PL NORMS IN RESPECT OF DRUG FORMULATIONS : QUESTIONNAIRE INDEX

Sl. No.	Proforma No.	Details
--	--	Guidelines
--	--	General Information
1	A	Installed / Achievable Capacity and Actual Production
2	B	Production and Process Loss Dosage form wise
3	C	Cost Centrewise Capacity and Production
4	C1	Assessment of Installed Capacity of Production Cost Centres
5	C2	Assessment of Installed Capacity of Packing Cost Centres
6	D	Break-up of Profit & Loss Account Unit-Wise
7	E	Reconciliation Statement
8	E1	Allocation of Depreciation to Formulation Activity
9	F	Re-allocation of Direct & Common Expenditure for Formulation Division – Unit-wise
10	G	Allocation of Expenses relating to own Formulation Activity – Unit-wise
11	H	Absorption of Converison Cost and Packing Cost to various Products
12	I	Production Data
13	J	Details of Process Loss and Packing Material Loss
14	K	Conversion Cost, Process Loss & Packing Charges in respect of Formulations
15	L	Processing Charges as per DPCO and Actually paid in respect of Loan Licence from Others
16	M	Processing Charges as per DPCO and Actually Recived in respect of Loan Licence for Others

Last Page Updated: 01-11-2018

Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)

QUESTIONNAIRE FOR CC PC AND PL